Join to View Full Profile
800 Rose StreetLexington, KY 40536
Phone+1 859-323-7507
Dr. Hao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Atrium Health Navicent The Medical Center/Mercer University School of MedicineResidency, Internal Medicine, 2004 - 2007- OtherClass of 1986
Certifications & Licensure
KY State Medical License 2023 - 2026
GA State Medical License 2009 - 2019
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung Cancer With Copanlisib and Durvalumab Start of enrollment: 2021 May 12
Roles: Principal Investigator, Contact, Sponsor-Investigator
- ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer Start of enrollment: 2022 Apr 01
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- New developments in immunotherapy for SCLC.Tsering Dolkar, Christopher Gates, Zhonglin Hao, Reinhold Munker
Journal for Immunotherapy of Cancer. 2025-01-06 - Radiotherapy in Managing Metastatic Hepatocellular Carcinoma With Cardiac Involvement and Pulmonary Tumor Thromboemboli: A Case Report.Zeta Chow, Evans Amoah, Zhonglin Hao, Mahesh Kudrimoti
Cureus. 2023-03-01 - 14 citationsPhase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancersMartin Gutierrez, Robin Guo, Giuseppe Giaccone, Stephen V. Liu, Zhonglin Hao
Lung Cancer. 2021-10-08
Press Mentions
Markey Hosts Two Breakthrough Cancer Vaccine TrialsJanuary 29th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
